ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,161.88
0.24%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. NASDAQ

  6. ETF Series Solutions Trust Range Cancer Therapeutics (CNCR) Share Price

CNCR ETF Series Solutions Trust Range Cancer Therapeutics

14.27
-0.40 (-2.73%)
14 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 ETF Series Solutions Trust Range Cancer Therapeutics NASDAQ:CNCR NASDAQ Exchange Traded Fund  ETF
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.40 -2.73 14.27 13.69 15.05 14.71 14.28 14.71 1,823 20:30:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Mgmt Invt Offices, Open-end 70k -4.62M -5.7713 -2.50 11.53M
 Type  Size  Price  Time  Units 
 9 1 14.01 22:56:24 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore CNCR News
23/10/202313:30PRNUSEXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION
Period
Draw mode
Data Downloads for CNCR

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest ETF Series Solutions Trust Range Cancer Therapeutics Articles